Pharmexcil, DIA to acquaint pharma SMEs about global standards.

In an endeavour to promote pharma exports, the Pharmaceuticals Export Promotion Council (PHARMEXCIL) has signed a memorandum of understanding (MoU) with the Drug Information Association (DIA) in India to acquaint Indian pharma-based SMEs with the latest rules and registration procedures followed in the international markets.

Speaking to a Bizxchange correspondent, Smitesh C Shah, chairman and managing director of PHARMEXCIL, said, “As a part of this tie-up with DIA, PHARMEXCIL will be training pharma-based SMEs about regulatory standards in use. Regular interactions with DIA will help us make pharma SMEs aware about the latest developments in the industry.”

In addition to Mr Shah’s comments, Dr PV Appaji, executive director of PHARMEXCIL, said, “DIA is a strong international body of professionals having chapters in several countries world over and they have members from industry and academia, among others. Today, the major requirement of SMEs in the Indian pharma sector is information on drug registration requirements in overseas countries and current good manufacturing practices (cGMP). With the support of DIA and its willingness to educate SMEs as per the request of Pharmexcil at reasonable fees, we are sure that SMEs would be highly benifitted from this MoU.”

As a part of the MoU, PHARMEXCIL and DIA will collaborate to share knowledge on technical developments in the sector and organise programmes to increase awareness about global drug registration, GMP requirements and clinical research procedures. This collaboration is in the best interests of pharma-based SMEs who are expected to export more and superior quality drugs now.

“This development will definitely benefit SMEs in the pharma sector that are often charged for manufacturing and supplying sub-standard quality drugs to other countries,” said Karan Bhalla, owner of Karan Health Care Pvt Ltd, a small-sized unit in New Delhi which manufactures and exports medicines.

Notably, the two industry bodies will be offering country-specific guidelines to SMEs to ward off any lapse in medical regulations compliance, thereby fuelling more exports.

Source : indiacompanynews.com